Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731171 · ClinicalTrials.gov registry record · NA
Probiotics to Prevent Relapse After Hospitalization for Mania
A NA study, sponsored by Sheppard Pratt Health System.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01731171: Completed NA study, sponsored by Sheppard Pratt Health System.
NCT01731171 is a NA study that has completed, run by Sheppard Pratt Health System. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01731171, a NA study, has completed, sponsored by Sheppard Pratt Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking a probiotic supplement versus a placebo will lower rates of relapse and improve the clinical course among participants who have been hospitalized for mania. Relapse and clinical course are measured by time to re-hospitalizations, new mood episodes, and changes in mood-related symptoms.
Primary Outcome
The primary outcome was the time to first psychiatric inpatient rehospitalization.
Interventions
- DIETARY_SUPPLEMENT Probiotic Supplement
- DIETARY_SUPPLEMENT Inert Compound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01731171 record still lists
NCT01731171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Probiotic Supplement is the first listed.
NCT01731171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01731171 about?
NCT01731171 is a clinical study titled "Probiotics to Prevent Relapse After Hospitalization for Mania". The purpose of this study is to determine if taking a probiotic supplement versus a placebo will lower rates of relapse and improve the clinical course among participants who have been hospitalized for mania. Relapse and clinical course are measured by time to re-hospitalizations, new mood episodes,...
What is the current status of trial NCT01731171?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2012-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01731171?
The interventions under investigation include: Probiotic Supplement (DIETARY_SUPPLEMENT), Inert Compound (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01731171?
This trial is sponsored by Sheppard Pratt Health System, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01731171's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia